G.M.P.E. SPRL
Ouverture de failliteThe score of G.M.P.E. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2006
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
G.M.P.E.'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2015filed on 22 Sep 2017
- Year ended 31 Dec 2014filed on 14 Jan 2016
- Year ended 31 Dec 2013filed on 12 Feb 2014
- Year ended 31 Dec 2012filed on 12 Feb 2014
- Year ended 31 Dec 2011filed on 12 Feb 2014
G.M.P.E.'s financial analysis
- Solvency0.3%sector median: 61.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of G.M.P.E.
G.M.P.E.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0458.361.325
- VAT number
- BE0458361325
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 27 Jun 1996
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2006 · filed on 22 Sep 2017
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
G.M.P.E. (SPRL) has been based in Anderlecht since 1996, active in: manufacture of basic pharmaceutical products. For 2006, it reports a net profit of — and equity of 2,409 €; its revenue is not published. Its solvency stands at 0.3%, below the median of its sector (61.2%).
Companies similar to G.M.P.E.
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Infoma Manufacture of basic pharmaceutical products Berchem-Sainte-Agathe · balance sheet 822,208 €
- Fourco Manufacture of basic pharmaceutical products Watermael-Boitsfort · balance sheet 910,913 €
- bioprojet benelux Manufacture of basic pharmaceutical products Molenbeek-Saint-Jean · balance sheet 673,084 €
- Saveur ET Delicatesse Manufacture of basic pharmaceutical products Woluwe-Saint-Pierre · balance sheet 636,073 €
- NICOLAS CLUMECK psychiatrie Manufacture of basic pharmaceutical products Uccle · balance sheet 615,727 €
- LE Groupe Odin Manufacture of basic pharmaceutical products Ixelles · balance sheet 571,856 €
- Pharma MAR Manufacture of basic pharmaceutical products Brussels · balance sheet 492,662 €
- Transsignaal Manufacture of basic pharmaceutical products Woluwe-Saint-Pierre · balance sheet 489,262 €
Frequently asked questions about G.M.P.E.
What is the revenue of G.M.P.E.?
G.M.P.E. files its accounts in a format where revenue is optional: it is not published for 2006.
What is the VAT number of G.M.P.E.?
In Belgium, the VAT number is the company number prefixed with BE: BE0458361325 for G.M.P.E., if the company is VAT-registered. Its company number (CBE) is 0458.361.325.
Where is the registered office of G.M.P.E.?
According to the CBE register, the registered office of G.M.P.E. is in 1070 Anderlecht.
What is the equity of G.M.P.E.?
At the close of the 2006 financial year, the equity of G.M.P.E. amounts to 2,409 €, a solvency of 0.3% of total assets.
Who manages G.M.P.E.?
The register lists 3 active mandates at G.M.P.E.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of G.M.P.E.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →